| Structure |
Chemical Name |
CAS |
MF |
 |
Apixaban Impurity 42 |
132577-23-2 |
C12H14N2O4 |
 |
2-(7-methoxy-3,4-dihydronaphthalen-1-yl)ethan-1-amine |
1353428-89-3 |
C13H17NO |
 |
Aripiprazole impurity 20 |
203395-83-9 |
|
 |
Aripiprazole Impurity 47 |
2250242-47-6 |
C27H33Cl2N3O3 |
 |
Afatinib impurity 45 |
99281-87-5 |
C5H9NO2 |
 |
Afatinib impurity 48 |
|
|
 |
Afatinib Impurity 57 |
|
|
 |
Afatinib Impurity ODQ |
|
|
 |
Afatinib Impurity QJJ |
2323570-72-3 |
C24H27ClFN5O4 |
 |
(S)-tert-butyl (1-(3-(2-cyanobenzyl) |
1618644-31-7 |
C23H29N5O4 |
 |
Afatinib impurity 82 |
|
|
![1H-Pyrazolo[3,4-c]pyridine-3-carboxamide, 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-](/CAS/20210305/GIF/1642569-42-3.gif) |
1H-Pyrazolo[3,4-c]pyridine-3-carboxamide, 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo- |
1642569-42-3 |
C20H17N5O5 |
![Benzonitrile, 2-[(3,4-dihydro-6-methoxy-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl]-](/CAS/20210305/GIF/2514763-78-9.gif) |
Benzonitrile, 2-[(3,4-dihydro-6-methoxy-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl]- |
2514763-78-9 |
C14H13N3O3 |
 |
Anastrozole Impurity 41 |
|
|
 |
2-アミノ-5,6-ジクロロ-3,4-ジヒドロキナゾリン |
444904-63-6 |
C8H7Cl2N3 |
 |
Anagrelide impurity 4 |
1092352-99-2 |
C10H6Cl3N3O |
![9-ethyl-8-iodo-6,6-diMethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile](/CAS/GIF/1256584-80-1.gif) |
9-ethyl-8-iodo-6,6-diMethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile |
1256584-80-1 |
C21H17IN2O |
 |
アゴメラチン二量体尿素 |
185421-27-6 |
C27H28N2O3 |
 |
Metabotropic glutamate receptor 5 (GRM5) Antibody |
|
|
 |
Amoxicillin related impurities K |
|
|
 |
アモキシシリンジケトピペラジン |
94659-47-9 |
C16H19N3O5S |
 |
bis(2-(7-Methoxynaphthalen-1-yl)ethyl)aMine |
1623104-92-6 |
C26H28ClNO2 |
 |
Anastrozole iMpurity |
|
|
![1-(4-Methoxyphenyl)-6-(4-(2-Methyl-6-oxopiperidin-1-yl)phenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxaMide](/CAS/20150408/GIF/CB02681131.gif) |
1-(4-Methoxyphenyl)-6-(4-(2-Methyl-6-oxopiperidin-1-yl)phenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxaMide |
2098457-92-0 |
C26H27N5O4 |
![臭化8-(2,3-ジクロロフェニル)-8-アザ-5-アゾニアスピロ[4.5]デカン](/CAS/GIF/795313-24-5.gif) |
臭化8-(2,3-ジクロロフェニル)-8-アザ-5-アゾニアスピロ[4.5]デカン |
795313-24-5 |
C14H19BrCl2N2 |
 |
Afatinib IMpurity D |
|
|
 |
AMoxicillin DiMer (penicilloic acid forM) |
210289-72-8 |
C32H40N6O11S2 |
 |
Alogliptin Impurity E |
|
|
![2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-4-ylmethyl)phenyl]-2-methyl-propaneni](/CAS/GIF/120511-92-4.gif) |
2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-4-ylmethyl)phenyl]-2-methyl-propaneni |
120511-92-4 |
C17H19N5 |
 |
Acarbose Impurity D |
|
|
 |
Acarbose Impurity C |
|
|
 |
Aripiprazole-Impurity 17 |
1424857-89-5 |
C16H17Cl4N3 |
 |
Apixaban Impurity 42 |
132577-23-2 |
C12H14N2O4 |
 |
2-(7-methoxy-3,4-dihydronaphthalen-1-yl)ethan-1-amine |
1353428-89-3 |
C13H17NO |
 |
Aripiprazole impurity 20 |
203395-83-9 |
|
 |
Aripiprazole Impurity 47 |
2250242-47-6 |
C27H33Cl2N3O3 |
 |
Afatinib impurity 45 |
99281-87-5 |
C5H9NO2 |
 |
Afatinib impurity 48 |
|
|
 |
Afatinib Impurity 57 |
|
|
 |
Afatinib Impurity ODQ |
|
|
 |
Afatinib Impurity QJJ |
2323570-72-3 |
C24H27ClFN5O4 |
 |
(S)-tert-butyl (1-(3-(2-cyanobenzyl) |
1618644-31-7 |
C23H29N5O4 |
 |
Cationic panthenol |
|
|
 |
Alogliptin iMpurity |
60271-06-9 |
C7H10N2O3 |
 |
(R)-2-((6-(3-((3-(2-cyanobenzyl)-1-Methyl-2,6-dioxo-1,2,3,6-tetrahydropyriMidin-4-yl)aMino)piperidin-1-yl)-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)benzonitrile |
1268836-55-0 |
C31H30N8O4 |
 |
AlMotriptan iMpurity |
|
|
 |
ニンヒドリン |
485-47-2 |
C9H6O4 |
 |
7-(2-デオキシアデノシン-N6-イル)アリストラクタムI |
127191-86-0 |
C27H22N6O7 |
 |
溶剤脱ワックス重質飽和炭化水素石油蒸留物 |
64742-65-0 |
|
 |
Free and total Chlorine, ion specific meter |
|
|
 |
1-(5-フルオロペンチル)-1H-インドール-3-カルボン酸1-ナフチル |
837112-21-7 |
C24H22FNO2 |
 |
MEGACELL™ ダルベッコ改変イーグル培地 |
|
|
 |
HYDROXYZINE HYDROCHLORIDE |
|
C21H28Cl2N2O2 |
 |
(1-ジアゾ-2-オキソプロピル)ホスホン酸ジメチル |
90965-06-3 |
C5H9N2O4P |
![Calcium bis[4-{[(1S,3R)-1-([1,1'-biphenyl]-4-ylmethyl)-3-methyl-4-oxo-4-(propan-2-yloxyl)butyl]amino}-4-oxobutanoate]](/CAS/20180629/GIF/CB02995780.gif) |
Calcium bis[4-{[(1S,3R)-1-([1,1'-biphenyl]-4-ylmethyl)-3-methyl-4-oxo-4-(propan-2-yloxyl)butyl]amino}-4-oxobutanoate] |
|
C50H60CaN2O10 |
 |
2,3‐デヒドロシリビンB |
142796-24-5 |
C25H20O10 |
![monocalciummono(4-(((2R,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy- 4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoate)](/CAS/20200119/GIF/CB05441222.gif) |
monocalciummono(4-(((2R,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy- 4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoate) |
|
C24H28CaNO5 |
 |
3-methyl-2-pentylphenol |
1823068-39-8 |
C12H18O |
 |
Afatinib impurity 82 |
|
|
![1H-Pyrazolo[3,4-c]pyridine-3-carboxamide, 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-](/CAS/20210305/GIF/1642569-42-3.gif) |
1H-Pyrazolo[3,4-c]pyridine-3-carboxamide, 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo- |
1642569-42-3 |
C20H17N5O5 |
![Benzonitrile, 2-[(3,4-dihydro-6-methoxy-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl]-](/CAS/20210305/GIF/2514763-78-9.gif) |
Benzonitrile, 2-[(3,4-dihydro-6-methoxy-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl]- |
2514763-78-9 |
C14H13N3O3 |
![5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(1E)-2-(4-methyl-5-thiazolyl)ethenyl]-8-oxo-7-[(2-phenylacetyl)amino]-, (4-methoxyphenyl)methyl ester, (6R,7R)-](/CAS/20210305/GIF/104146-11-4.gif) |
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(1E)-2-(4-methyl-5-thiazolyl)ethenyl]-8-oxo-7-[(2-phenylacetyl)amino]-, (4-methoxyphenyl)methyl ester, (6R,7R)- |
104146-11-4 |
C29H27N3O5S2 |
 |
Anastrozole Impurity 41 |
|
|
 |
(2R-TRANS)-ジルチアゼム塩酸塩 |
103532-27-0 |
C22H27ClN2O4S |
 |
2-アミノ-5,6-ジクロロ-3,4-ジヒドロキナゾリン |
444904-63-6 |
C8H7Cl2N3 |
 |
Anagrelide impurity 4 |
1092352-99-2 |
C10H6Cl3N3O |
![2'-[(1H-テトラゾール-5-イル)ビフェニル-4-イル]メタノール](/CAS/GIF/160514-13-6.gif) |
2'-[(1H-テトラゾール-5-イル)ビフェニル-4-イル]メタノール |
160514-13-6 |
C14H12N4O |
![9-ethyl-8-iodo-6,6-diMethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile](/CAS/GIF/1256584-80-1.gif) |
9-ethyl-8-iodo-6,6-diMethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile |
1256584-80-1 |
C21H17IN2O |
 |
アゴメラチン二量体尿素 |
185421-27-6 |
C27H28N2O3 |
 |
Alogliptin iMpurity |
60271-06-9 |
C7H10N2O3 |
 |
(R)-2-((6-(3-((3-(2-cyanobenzyl)-1-Methyl-2,6-dioxo-1,2,3,6-tetrahydropyriMidin-4-yl)aMino)piperidin-1-yl)-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)benzonitrile |
1268836-55-0 |
C31H30N8O4 |
 |
AlMotriptan iMpurity |
|
|
 |
Anastrozole IMpurity (3-(1-Cyano-1-Methylethyl)-alfa,alfa-diMethyl-5-(1H-,1,2,4-triazole-1-ylMethyl)-benzeneacetic acid) |
1338800-82-0 |
C17H20N4O2 |
 |
Aripiprazole iMpurity 4 |
1424857-63-5 |
C36H42Cl2N4O4 |
![(2R,4S)-4-([1,1'-Biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoic acid](/CAS/20180702/GIF/1639970-62-9.gif) |
(2R,4S)-4-([1,1'-Biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoic acid |
1639970-62-9 |
C22H23NO4 |
 |
Alogliptin Impurity B |
865758-98-1 |
C17H19N5O2 |
 |
Ofloxacin/Levofloxacin Impurity A |
|
|
 |
methyl(E)-4-(methylamino)but-2-enoate |
915788-22-6 |
C6H11NO2 |
 |
ethyl 4-dimethylamino-3-hydroxy-butanoate |
90227-57-9 |
C8H17NO3 |
 |
(E)-N-(2-(7-methoxy-3,4-dihydronaphthalen-1(2H)-ylidene)ethyl)acetamide |
178677-39-9 |
C15H19NO2 |
 |
Aripiprazole Impurity 11 |
|
|
 |
(R)-2-((3-methyl-6-(3-((1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile |
|
C23H25N7O4 |
 |
Acarbose Impurity H |
|
|
 |
Anastrozole EP Impurity I |
120511-91-3 |
C15H17ClN2 |
 |
Afatinib Impurity 74 |
1259015-90-1 |
C7H13NO2 |
 |
Afatinib Impurity 78 |
|
|
 |
Anastrozole Impurity I |
|
|
 |
(R,R)-Palonosetron N-Oxide |
|
C19H24N2O2 |
 |
7-PACE Impurity 2 |
|
|
 |
N2-Methyl Alfuzosin Hydrochloride |
72104-34-8 |
C19H28ClN5O4 |
 |
Anastrozole iMpurity A |
|
|
 |
Desloratadine IMpurity 3 |
1346600-61-0 |
C19H19ClN2 |
 |
EMpagliflozin iMpurity 11 |
|
|
 |
LCZ Impurity |
753421-85-1 |
C20H25NO2 |
![(3S,5R)-4-[5-([1,1'-Biphenyl]-4-ylmethyl)-3-methyl-2-oxopyrrolidin-1-yl]-4-oxobutanoic acid](/CAS/20180702/GIF/CB22995779.gif) |
(3S,5R)-4-[5-([1,1'-Biphenyl]-4-ylmethyl)-3-methyl-2-oxopyrrolidin-1-yl]-4-oxobutanoic acid |
|
C22H23NO4 |
![Ethyl (2R,4S)-4-([1,1'-biphenyl]-4-ylmethyl)-4-[4-(propan-2-yloxy)-4-oxobutanamido]-2-methylbutanoate](/CAS/20180702/GIF/CB22995784.gif) |
Ethyl (2R,4S)-4-([1,1'-biphenyl]-4-ylmethyl)-4-[4-(propan-2-yloxy)-4-oxobutanamido]-2-methylbutanoate |
|
C27H35NO5 |
 |
Formoterol EP Impurity E |
1616967-26-0 |
C20H26N2O4 |
 |
(Glu3)-Carbetocin (Impurity D) |
|
|
 |
Δ3-7-ACT |
|
|
![(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoic acid hydrochloride](/CAS/20150408/GIF/1038924-71-8.gif) |
(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoic acid hydrochloride |
1038924-71-8 |
C18H22ClNO2 |